Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Inform Diagnostics, Inc | $38.55 | 124.7K |
| Texas Digestive Disease... | $52.66 | 102.0K |
| Propath Services, Llc | $50.44 | 74.4K |
| Cockerell Dermatopathology Pa | $48.65 | 65.8K |
| Chisholm, Cary M.D. | $37.95 | 50.5K |
| Sinkre, Prasanna MD | $27.36 | 23.3K |
| Martin, Howard MD | $49.71 | 21.8K |
| Ameripath Texas, Inc. | $30.39 | 19.6K |
| Graham, Bradley MD | $48.49 | 16.6K |
| Watkins, Jeremiah M.D. | $53.07 | 15.8K |
| Lee, Keagan M.D. | $54.91 | 15.5K |
| Yalamanchili, Rajesh M.D. | $47.98 | 13.2K |
| Whittemore, Darren DO | $50.22 | 12.4K |
| Wofford, John MD | $51.17 | 12.3K |
Texas Pricing in Context
In Texas, CPT code 88305 (Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity) carries an average Medicare payment of $39.68 — 2% above the national benchmark of $38.77. 1.7K providers across the state submitted claims for this procedure in 2023, performing 1.5M total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $222.08, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Pathology procedures, the estimated commercial insurance price in Texas lands near $120.88, with self-pay cash prices typically around $100.49. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity cost in Texas?
The average Medicare payment for Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity in Texas is $39.68, which is 2% above the national average of $38.77. Providers in TX typically bill $222.08 for this procedure.
What does Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity cost with insurance in Texas?
With commercial insurance in Texas, Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity costs an estimated $120.88. Without insurance, the estimated cash price is $100.49. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity in Texas?
1.7K providers in Texas billed Medicare for Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity in 2023, performing 1.5M total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity cheaper in Texas than the national average?
No — Pathology Examination Of Tissue Using A Microscope, Intermediate Complexity costs 2% above the national average in Texas. The state average Medicare payment is $39.68 compared to $38.77 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.